Caribou plans a pivotal Phase 3 randomized trial evaluating approximately 250 patients in second-line large B-cell lymphoma. The FDA granted vispa-cel Regenerative Medicine Advanced Therapy, Orphan ...
Diginex remains in active and constructive dialogue with Resulticks Global Companies Pte Limited (“Resulticks”), with final terms to the definitive transaction documentation now agreed to and deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback